Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SE & CO. KGAA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical : Conference Call Prńsentation

05/06/2021 | 01:25am EST

Q1|2021

Investor/Analyst Call

Dr. Dirk Wössner, CEO

Michael Rauch, CFO

May 6, 2021

Disclaimer

The information provided in this presentation pertaining to CompuGroup Medical SE & Co. KGaA (the "Company"), comprise the written materials/slides for presentations or discussions on the occasion of an investor conference, meeting or conference call ("Meeting"). Whilst all reasonable care has been taken to ensure that the information and facts stated herein as well as oral statements made in the Meeting are accurate and that the opinions and expectations contained herein and orally received during the Meeting are fair and reasonable, no representation or warranty, express or implied, is given by or on behalf of the Company, any of its board members, or any other person as to the accuracy or completeness of the information and/or opinions and no liability as to the accuracy of such information and/or opinions is accepted. The information provided in this presentation as well as during the Meeting contain forward looking statements which involve risks and uncertainties. These forward-looking statements speak only as of the date of the documents and are based on numerous assumptions which may or may not prove to be correct. The actual performance and results of the business of the Company could differ materially from the performance and results discussed in this document or in any other information received during the Meeting. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements or other information contained herein or received during the Meeting whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Readers are cautioned not to place undue reliance on forward-looking statements or financial projections. The information contained in this presentation and/or received during the Meeting does not constitute or form any part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto.

2

May 6, 2021

Q1/21 Investor & Analyst Call

GROUP

OVERVIEW

DR. DIRK WÖSSNER, CEO

3

Q1 - An excellent start into 2021

€229m

69%

+5%

€47m

20%

€0.33

€70m

(+25%yoy)

(+2ppt)

(+3ppt)

(+7%yoy)

(-4ppt)

(PY: €0.34)

(PY: €51m)

Revenue

Recurring

Organic

Adj.

Margin

Adj. EPS

FCF

rev share

growth

EBITDA

4

May 6, 2021

Q1/21 Investor & Analyst Call

We are passionately supporting…

… our customers: doctors, nurses and all other healthcare professionals in their courageous fight against COVID-19.

5

May 6, 2021

Q1/21 Investor & Analyst Call

Um den Rest dieser Noodl zu lesen, rufen Sie bitte die Originalversion auf, und zwar hier.

Disclaimer

CompuGroup Medical SE published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2021 05:24:02 UTC.


ę Publicnow 2021
All news about COMPUGROUP MEDICAL SE & CO. KGAA
01/20COMPUGROUP MEDICAL SE & CO. KGAA : Notification and public disclosure of transactions by p..
EQ
01/19COMPUGROUP MEDICAL : Berenberg reaffirms its Buy rating
MD
01/18COMPUGROUP MEDICAL : Buy rating from Baader Bank
MD
01/18CompuGroup Medical expects continued strong organic growth in 2022 and first step towar..
EQ
01/18CompuGroup Medical SE & Co. KGaA Announces Delay in Publication of the Preliminary Resu..
CI
01/18CompuGroup Medical SE & Co. KGaA Provides Revenue Guidance for the Fiscal Year 2021 and..
CI
01/14COMPUGROUP MEDICAL : Kepler Cheuvreux gives a Buy rating
MD
01/11COMPUGROUP MEDICAL : Raised from Sell to Buy by Baader Bank
MD
01/10COMPUGROUP MEDICAL SE & CO. KGAA : Share Buy-Back Program - 6th Interim Announcement, conc..
EQ
01/03COMPUGROUP MEDICAL SE & CO. KGAA : Share Buy-Back Program - 5th Interim Announcement
EQ
More news
Analyst Recommendations on COMPUGROUP MEDICAL SE & CO. KGAA
More recommendations
Financials
Sales 2021 1 022 M 1 153 M 1 153 M
Net income 2021 79,2 M 89,4 M 89,4 M
Net Debt 2021 535 M 604 M 604 M
P/E ratio 2021 38,3x
Yield 2021 0,89%
Capitalization 2 985 M 3 367 M 3 369 M
EV / Sales 2021 3,44x
EV / Sales 2022 3,17x
Nbr of Employees 8 079
Free-Float -
Chart COMPUGROUP MEDICAL SE & CO. KGAA
Duration : Period :
CompuGroup Medical SE & Co. KGaA Technical Analysis Chart | COP | DE000A288904 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 56,70 €
Average target price 84,25 €
Spread / Average Target 48,6%
EPS Revisions
Managers and Directors
Dirk W÷ssner Chairman-Management Board & CEO
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas MŘller Chief Information Officer
Ulrike Handel Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SE & CO. KGAA-20.31%3 367
ORACLE CORPORATION-7.04%216 493
SAP SE-6.63%155 175
SERVICENOW, INC.-23.73%98 518
CONSTELLATION SOFTWARE INC.-13.93%33 893
DOCUSIGN, INC.-22.66%23 310